1. W. Zumkeller. The role of insulin-like growth factor system in soft tissue sarcomas: from physiopathology to targeted therapeutic approaches//Sarcoma. 1998; 2 (2): 69–76.
2. Hemkens L. G., Grouven U., Bender R., Gunster C, Gutshmidt S., Selke G. W., Sawicki P. T. Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study//Diabetologia. 2009; 52: 1732-44.
3. Colhoun H. M. SDRN Epidemiology Group. Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Work Epidemiology Group//Diabetologia. 2009; 52: 1755-65.
4. Currie C. J., Poole C. D., Gale E. A. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes//Diabetologia. 2009; 52:1766-77.